Nevada mandates health plans cover STD testing and prevention starting October 2025

On April 24, 2025, the Nevada State Legislature introduced Assembly Bill 522, a significant piece of legislation aimed at enhancing healthcare access and coverage for sexually transmitted diseases (STDs) and related preventive measures. The bill mandates that health benefit plans provide comprehensive coverage for testing, treatment, and prevention of STDs, including but not limited to Chlamydia, gonorrhea, syphilis, HIV, and hepatitis B and C, for all insured individuals, regardless of age.

Key provisions of AB522 include the requirement for health carriers to offer unrestricted coverage of condoms for individuals aged 13 and older. Additionally, the bill prohibits health carriers from imposing higher deductibles, copayments, or longer waiting periods for these benefits. It also prevents insurers from canceling or refusing to issue health plans based solely on an individual's use of these benefits, and it prohibits financial incentives that might discourage insured individuals from accessing necessary care.

The bill's introduction has sparked notable discussions among lawmakers and stakeholders. Proponents argue that AB522 is a crucial step toward reducing the stigma associated with STDs and ensuring equitable access to essential health services. They emphasize the importance of preventive care in combating the spread of STDs and improving public health outcomes.

Opponents, however, have raised concerns regarding the potential financial implications for health carriers and the overall healthcare system. Some argue that the mandated coverage could lead to increased premiums for consumers, while others question the feasibility of implementing such comprehensive coverage without additional funding or resources.

The implications of AB522 extend beyond healthcare access; they touch on broader social and political issues, including public health policy, reproductive rights, and health equity. Experts suggest that if passed, the bill could serve as a model for other states looking to enhance healthcare coverage for STDs and related services.

As the legislative process unfolds, AB522 is poised to be a focal point of debate in Nevada, with potential ramifications for healthcare policy and public health initiatives in the state. The bill is scheduled for further discussion in upcoming legislative sessions, where its fate will be determined.